Lemaitre Vascular INC Form 4 insider transactions

Lemaitre Vascular's Senior VP of Operations, Trent G. Kamke, acquired dividend equivalent rights tied to existing equity awards.

Lemaitre Vascular's Senior VP of Operations, Trent G. Kamke, exercised stock options and subsequently sold the acquired shares.

Lemaitre Vascular President and Director David B. Roberts sold 3,311.68 shares of common stock on March 11, 2026, at a weighted average price of $107.6752 per share.

Lemaitre Vascular CFO Dorian Paul LeBlanc reported the acquisition of 2 shares and the disposition of 96 shares for tax withholding related to RSU vesting.

Lemaitre Vascular Director Martha Shadan acquired 477 shares of common stock through the settlement of a performance share unit award and dividend equivalent rights.

Lemaitre Vascular Director John Roush acquired 477 shares of common stock through the settlement of a Performance Share Unit award and dividend equivalent rights.

Lemaitre Vascular Director Bridget A. Ross acquired 477 shares of common stock through the vesting of performance share units and dividend equivalent rights.

Lemaitre Vascular Director John James O'Connor acquired 477 shares of common stock through the settlement of a performance share unit award and dividend equivalent rights.

Lemaitre Vascular Director Lawrence J. Jasinski acquired common stock through performance share unit settlement and dividend equivalent rights.

Joseph P. Pellegrino Jr., a Director at Lemaitre Vascular Inc., acquired 1,897 shares of common stock through the vesting of a Performance Share Unit award and related dividend equivalent rights.

Lemaitre Vascular's Senior VP of Operations, Trent G. Kamke, sold 1,044 shares of common stock following the vesting of performance share units and dividend equivalent rights.

Lemaitre Vascular's President and Director, David B. Roberts, reported the acquisition of common stock from vested performance share units and subsequent sale of 8,464 shares.

LeMaitre Vascular's Chairman and CEO, George W. LeMaitre, reported significant stock sales and the vesting of performance share units.

Lemaitre Vascular's President and Director, David B. Roberts, exercised stock options to acquire 2,679 shares of common stock on February 5, 2026.

A Lemaitre Vascular Senior VP filed a Form 4 detailing future stock option exercises under a Rule 10b5-1 trading plan.

LEMAITRE VASCULAR INC's Chairman and CEO, George W. LeMaitre, reported multiple transactions including option exercises, RSU/PSU vestings, and a gift to a trust.

Lemaitre Vascular President and Director David B. Roberts reported recent stock transactions involving the vesting of restricted and performance stock units and associated tax withholdings.

Lemaitre Vascular's Senior VP of Operations, Trent G. Kamke, reported recent stock acquisitions from vested dividend equivalent rights and dispositions for tax withholding.

Joseph P. Pellegrino JR, a Director at Lemaitre Vascular Inc., increased his direct beneficial ownership by 61 shares through the vesting of restricted and performance stock units.

Lemaitre Vascular Director Martha Shadan acquired 10 shares of common stock through the vesting of restricted and performance stock unit awards.

Lemaitre Vascular Director Bridget A. Ross acquired 10 shares of common stock through the vesting of dividend equivalent rights, increasing her beneficial ownership.

Lemaitre Vascular Director John James O'Connor acquired 10 shares of common stock through the vesting of dividend equivalent rights.

Lemaitre Vascular Director Lawrence J. Jasinski acquired 10 shares of common stock through the vesting of restricted and performance stock units.

Lemaitre Vascular Director John A. Roush acquired 10 shares of common stock through the release of dividend equivalent rights from previously granted equity awards.

Lemaitre Vascular's Senior VP of Operations, Trent G. Kamke, acquired 1,177 restricted stock units and 7,222 stock options.

LeMaitre Vascular's Chairman and CEO, George W. LeMaitre, received restricted stock units and stock options as part of his compensation package.

Lemaitre Vascular's CFO, Dorian Paul LeBlanc, was granted 1,177 restricted stock units and 7,222 stock options as part of an equity compensation plan.

Lemaitre Vascular's President and Director, David B. Roberts, was granted 1,694 restricted stock units and 10,400 stock options.

LEMAITRE VASCULAR Director Joseph P. Pellegrino JR acquired 533 shares of common stock and 3,431 stock options on December 10, 2025, as part of equity awards.

Lemaitre Vascular Director Lawrence J. Jasinski acquired 533 restricted stock units and 3,431 stock options, increasing his beneficial ownership in the company.